Drug Channels

JUNE 5, 2023

View the Agenda Snapshot Enhance Patient Service, Network Design, and Channel Strategies to Improve Patient Access and Support In its 8th year, the Specialty Network and Patient Support Services Summit is an important event for senior leaders in patient access, trade, channel, market access, brand and account strategy.

Specialty Pharmacies 74

Specialty Pharmacies Biosimilars 74

Drug Channels

APRIL 27, 2021

While we all roll up our sleeves for a full reopening, let’s spring into this month’s selection of noteworthy news: Thoughts on Cigna’s payments to patients for non-medical switching 340B’s explosive specialty pharmacy growth An excellent analysis of GoodRx Plus, my $0.02 drug pricing policy. 3, and more.

Specialty Pharmacies 40

Specialty Pharmacies Drug Pricing Biosimilars 40

Drug Channels

MAY 27, 2020

Before you venture outside for your lockdown barbeque, check out these noteworthy items off the Drug Channels grill: Payers predict how COVID-19 will affect formularies Our analysis of the 2020 retail-to-mail shift AmerisourceBergen profiles biosimilars Plus, CVS pharmacy offers a clever way to measure appropriate social distancing.

Biosimilars 52

Biosimilars Specialty Pharmacies Hospitals 52

Big Molecule Watch

OCTOBER 18, 2023

has also signed a deal with a specialty pharmacy chain CarePartners Pharmacy to supply YUFLYMA (adalimumab-aaty). CarePartners Pharmacy, based in the Chicago metro area states that it is currently licensed to serve patients in 50 states and D.C.,

Specialty Pharmacies 69

Specialty Pharmacies Biosimilars 69

Drug Channels

NOVEMBER 9, 2022

During the event, Dr. Fein will share his latest thinking on a wide range of topics, including: Retail and specialty pharmacy trends Vertical integration and consolidation The Inflation Reduction Act of 2022 The Medicare Part D Redesign Biosimilars Discount cards and cash-pay pharmacies The growing impact of hospitals and health systems The 340B Drug (..)

Specialty Pharmacies 98

Specialty Pharmacies Drug Pricing Biosimilars Hospitals 98

Drug Channels

NOVEMBER 23, 2021

In this issue: The State of Specialty Pharmacy 2021 How health plans profit—and patients lose—from insulin A fantastic new analysis of the gross-to-net bubble CVS acknowledges how its PBM profits from 340B Reconsidering Amazon P.S. You can also find my daily posts on LinkedIn , where I have more than 21,000 followers.

Specialty Pharmacies 40

Specialty Pharmacies Drug Pricing Biosimilars Hospitals 40

Drug Channels

FEBRUARY 22, 2022

As always, we have updated all market and industry data with the most current information available, including our annual analyses of the market positions of the largest pharmacies, specialty pharmacies, and PBMs. This 2022 edition addresses COVID-19 and its ongoing impact on the pharmacy and PBM industries.

Specialty Pharmacies 96

Specialty Pharmacies Drug Pricing Biosimilars Vaccines 96

Drug Channels

NOVEMBER 15, 2021

PLUS: During the webinar, Dr. Fein will give participants an opportunity to unmute themselves and ask live questions.

Specialty Pharmacies 72

Specialty Pharmacies Drug Pricing Biosimilars 72

Drug Channels

NOVEMBER 8, 2021

LANDSCAPE ADDRESS: Analyze Market Dynamics and Trends Impacting the Channel in an Ever-Changing Environment POLICY ADDRESS: Break Down Evolving Regulatory Reform Driving Innovation and Access Predict Novel Reimbursement Mechanisms and First Pharmacy Benefits for Biosimilars Download your copy of the agenda today and join Informa Connect in December!

Specialty Pharmacies 75

Specialty Pharmacies Biosimilars 75

Drug Channels

NOVEMBER 24, 2020

My recent tweets have highlighted: doctors against step therapy, distribution of COVID-19 therapies, biosimilar savings, copay accumulator data, prospects for smaller PBMs, the new transparency rule, specialty pharmacy profit metrics, the future of oncology practices, and an update on Diplomat founder Phil Hagerman.

Specialty Pharmacies 52

Specialty Pharmacies Biosimilars Hospitals 52

Drug Channels

FEBRUARY 21, 2023

As always, we have updated all market and industry data with the most current information available, including our annual analyses of the market positions of the largest pharmacies, specialty pharmacies, and PBMs.

Specialty Pharmacies 97

Specialty Pharmacies Drug Pricing Biosimilars 97

Pharmacy Times

MAY 4, 2023

Gregory also discussed the differences between specialty pharmacy distribution and physician’s office distribution, and the benefits of each for patients.

Specialty Pharmacies 26

Specialty Pharmacies Biosimilars 26

HealthPartners

JULY 21, 2021

We negotiate the lowest pricing in our network of retail pharmacies, mail order pharmacy and specialty pharmacy partnerships. Excellent member experience It’s hard to lower your pharmacy costs if your members aren’t getting adequate support to follow their therapies correctly and start feeling better.

Biosimilars 52

Biosimilars Specialty Pharmacies Mail-Order Pharmacies Health Insurance Companies 52

Drug Channels

OCTOBER 10, 2023

Drug Distribution Industry Gaining from Anti-Obesity Drugs and Provider-Administered Biosimilars (press release) We’re offering special discounted pricing if you order before October 20, 2023! reviews the evolving specialty pharmacy industry and discusses emerging challenges from direct distribution models that bypass wholesale distribution.

Specialty Pharmacies 40

Specialty Pharmacies Biosimilars Pharmaceutical Manufacturing Documentation 40

Putting Patients First Blog

JANUARY 27, 2025

By adopting these proposals alongside the recommended enhancements, CMS can establish a transparent and equitable pharmacy network system that prioritizes patient access, supports provider sustainability, and ensures care continuity for Medicare beneficiaries.

Insurance Coverage and Processing 40

Insurance Coverage and Processing Biosimilars Communication Department of Veterans Affairs 40